Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Revenue (2020 - 2025)

Historic Revenue for Mereo BioPharma (MREO) over the last 5 years, with Q2 2025 value amounting to $500000.0.

  • Mereo BioPharma's Revenue changed N/A to $500000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $320000.0, marking a year-over-year decrease of 6800.0%. This contributed to the annual value of $10.0 million for FY2023, which is N/A changed from last year.
  • Mereo BioPharma's Revenue amounted to $500000.0 in Q2 2025.
  • Over the past 5 years, Mereo BioPharma's Revenue peaked at $9.0 million during Q2 2023, and registered a low of -$3.8 million during Q4 2021.
  • In the last 4 years, Mereo BioPharma's Revenue had a median value of -$180000.0 in 2025 and averaged $153899.9.
  • Its Revenue has fluctuated over the past 5 years, first plummeted by 13532.09% in 2021, then surged by 34267.39% in 2023.
  • Mereo BioPharma's Revenue (Quarter) stood at -$3.8 million in 2021, then grew by 1.85% to -$3.7 million in 2022, then skyrocketed by 126.96% to $1.0 million in 2023, then tumbled by 50.0% to $500000.0 in 2025.
  • Its Revenue stands at $500000.0 for Q2 2025, versus -$180000.0 for Q1 2025 and $1.0 million for Q4 2023.